Krsnaa Diagnostics Limited
NSE: KRSNAA BSE: KRSNAA
Prev Close
804
Open Price
809.95
Volume
66,333
Today Low / High
794 / 821.6
52 WK Low / High
625.75 / 1044
Range
758 - 838
Prev Close
803.2
Open Price
811.65
Volume
4,349
Today Low / High
793.85 / 820.25
52 WK Low / High
628 / 1041.8
Range
759 - 839
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 798.05 (target range: 758 - 838), reflecting a change of -5.95 (-0.74005%). On the BSE, it is listed at 798.7 (target range: 759 - 839), showing a change of -4.5 (-0.56026%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Krsnaa Diagnostics Limited Graph
Krsnaa Diagnostics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Krsnaa Diagnostics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 798.05, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 798.70 | 806.69 | 726.02 - 887.36 |
| 814.67 | 651.74 - 977.61 | ||
| 822.66 | 575.86 - 1,069.46 | ||
| Bearish Scenario | 798.70 | 790.71 | 711.64 - 869.78 |
| 782.73 | 626.18 - 939.27 | ||
| 774.74 | 542.32 - 1,007.16 |
Overview of Krsnaa Diagnostics Limited
ISIN
INE08LI01020
Industry
Medical - Diagnostics & Research
Vol.Avg
111,212
Market Cap
25,887,680,594
Last Dividend
2.5
Official Website
IPO Date
2021-08-16
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of KRSNAA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-12 | September 12, 25 | 2.75 | 2.75 | 2025-09-12 | 2025-10-25 | |
| 2024-09-13 | September 13, 24 | 2.5 | 2.5 | 2024-09-13 | 2024-10-21 | |
| 2023-09-15 | September 15, 23 | 2.75 | 2.75 | |||
| 2022-09-15 | September 15, 22 | 2.5 | 2.5 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 717.16 Cr | 169.26 Cr | 547.90 Cr | 0.7640 | 0.00 Cr | 60.68 Cr | 101.80 Cr | 77.61 Cr | 24.04 | 190.13 Cr | 0.1082 |
| 2024-03-31 | 619.63 Cr | 414.98 Cr | 204.65 Cr | 0.3303 | 0.00 Cr | 10.07 Cr | 71.19 Cr | 56.84 Cr | 17.90 | 161.04 Cr | 0.0917 |
| 2023-03-31 | 487.12 Cr | 74.18 Cr | 412.94 Cr | 0.8477 | 0.00 Cr | 8.15 Cr | 69.24 Cr | 62.11 Cr | 19.78 | 141.68 Cr | 0.1275 |
| 2022-03-31 | 455.45 Cr | 60.30 Cr | 395.15 Cr | 0.8676 | 0.00 Cr | 6.44 Cr | 90.34 Cr | 68.39 Cr | 22.89 | 146.39 Cr | 0.1502 |
| 2021-03-31 | 396.46 Cr | 83.75 Cr | 312.71 Cr | 0.7888 | 0.00 Cr | 10.79 Cr | 56.88 Cr | 184.93 Cr | 58.90 | 358.83 Cr | 0.4665 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 68.44 Cr | 1,281.60 Cr | 398.83 Cr | 882.7700 Cr | 203.53 Cr | 135.09 Cr | 29.48 Cr | 670.40 Cr | 0.00 Cr | 0.00 Cr | 31.54 Cr | 305.3880 Cr |
| 2024-03-31 | 2.38 Cr | 1,171.91 Cr | 362.11 Cr | 809.8020 Cr | 159.79 Cr | 157.41 Cr | 35.81 Cr | 690.93 Cr | 0.11 Cr | 0.00 Cr | -18.22 Cr | 281.4660 Cr |
| 2023-03-31 | 22.72 Cr | 909.89 Cr | 171.16 Cr | 738.7360 Cr | 32.48 Cr | 9.76 Cr | 25.07 Cr | 493.33 Cr | 26.58 Cr | 0.01 Cr | 155.62 Cr | 99.1940 Cr |
| 2022-03-31 | 88.45 Cr | 876.15 Cr | 207.44 Cr | 668.7100 Cr | 34.98 Cr | -53.47 Cr | 9.17 Cr | 411.64 Cr | 55.17 Cr | 1.95 Cr | 103.96 Cr | 148.7960 Cr |
| 2021-03-31 | 24.68 Cr | 604.53 Cr | 372.67 Cr | 231.8650 Cr | 231.78 Cr | 207.10 Cr | 7.21 Cr | 311.00 Cr | -63.83 Cr | 3.30 Cr | 2.70 Cr | 183.8050 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 87.3270 Cr | -99.6090 Cr | 13.7530 Cr | -39.3000 Cr | 1.4710 Cr | 3.8460 Cr | -126.6270 Cr | 77.6080 Cr | 58.8210 Cr | -8.0720 Cr | 6.3310 Cr |
| 2024-03-31 | 24.3450 Cr | -128.8770 Cr | 84.1870 Cr | -169.5420 Cr | -20.3450 Cr | 2.3750 Cr | -193.8870 Cr | 56.8370 Cr | 90.2210 Cr | -8.6290 Cr | -10.7330 Cr |
| 2023-03-31 | 76.3010 Cr | -108.8890 Cr | -33.1450 Cr | -65.0590 Cr | -65.7330 Cr | 22.7200 Cr | -141.3600 Cr | 80.2010 Cr | -9.1300 Cr | -7.8490 Cr | -15.9040 Cr |
| 2022-03-31 | 128.4240 Cr | -240.6360 Cr | 175.9900 Cr | -3.7950 Cr | 63.7780 Cr | 88.4530 Cr | -132.2190 Cr | 86.5100 Cr | -189.3720 Cr | 0.0000 Cr | -1.9610 Cr |
| 2021-03-31 | 102.5580 Cr | -61.1390 Cr | 30.8400 Cr | 35.7180 Cr | 72.2590 Cr | 24.6750 Cr | -66.8400 Cr | 295.4520 Cr | 55.5270 Cr | 0.0000 Cr | -2.1430 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 186.08 Cr | 41.55 Cr | 144.53 Cr | 0.7767 | 94.34 Cr | 20.68 Cr | 6.40 | 53.11 Cr | 0.1111 |
| 2024-12-31 | 174.51 Cr | 53.47 Cr | 121.04 Cr | 0.6936 | 22.37 Cr | 19.42 Cr | 6.01 | 54.31 Cr | 0.1113 |
| 2024-09-30 | 186.34 Cr | 119.53 Cr | 66.81 Cr | 0.3586 | 27.20 Cr | 19.60 Cr | 6.07 | 53.99 Cr | 0.1052 |
| 2024-06-30 | 170.23 Cr | 109.79 Cr | 60.45 Cr | 0.3551 | 21.20 Cr | 17.92 Cr | 5.55 | 49.98 Cr | 0.1053 |
| 2024-03-31 | 133.23 Cr | 41.69 Cr | 91.54 Cr | 0.6871 | 20.61 Cr | 18.92 Cr | 6.02 | 39.15 Cr | 0.1420 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 68.44 Cr | 0.00 Cr | 68.44 Cr | 277.75 Cr | 29.48 Cr | 414.47 Cr | 670.40 Cr | 1,281.60 Cr | 398.83 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 62.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -840.76 Cr |
| 2024-09-30 | 11.28 Cr | 51.34 Cr | 62.62 Cr | 243.47 Cr | 30.69 Cr | 417.31 Cr | 689.81 Cr | 1,294.54 Cr | 453.78 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 53.55 Cr | 0.00 Cr | 0.00 Cr | 53.55 Cr | 0.00 Cr | 0.00 Cr | -809.80 Cr |
| 2024-03-31 | 53.55 Cr | 194.25 Cr | 53.55 Cr | 195.40 Cr | 35.81 Cr | 421.19 Cr | 654.57 Cr | 1,171.91 Cr | 362.11 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 20.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 19.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 19.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 17.92 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 18.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Diagnostics & Research
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | ₹3,295.40 | ₹275,334,090,625.00 | ₹98,392.00 |
| Metropolis Healthcare Limited | METROPOLIS | ₹2,125.60 | ₹110,110,118,640.00 | ₹119,608.00 |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹1,058.00 | ₹108,642,962,380.00 | ₹83,492.00 |
| Thyrocare Technologies Limited | THYROCARE | ₹1,376.20 | ₹72,930,893,280.00 | ₹325,459.00 |
| Vimta Labs Limited | VIMTALABS | ₹660.40 | ₹29,391,498,240.00 | ₹2,159,159.00 |
| Krsnaa Diagnostics Limited | KRSNAA | ₹798.05 | ₹25,887,680,594.00 | ₹66,333.00 |
Key Executives
Gender: male
Year Born: 1986
Gender: male
Year Born:
Gender: male
Year Born: 1975
Gender: male
Year Born: 1986
Gender: male
Year Born: 1982
Gender: male
Year Born:
Gender: Not Specified
Year Born:
FAQs about Krsnaa Diagnostics Limited
The CEO is Mitesh Dave.
The current price is ₹798.05.
The range is ₹625.75-1044.
The market capitalization is ₹2,588.77 crores.
The dividend yield is 0.31%.
The P/E ratio is 33.86.
The company operates in the Healthcare sector.
Overview of Krsnaa Diagnostics Limited (ISIN: INE08LI01020) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹2,588.77 crores and an average daily volume of 111,212 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹2.5.